StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) income statement

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/3049% below fair value
$25.18+1.40 (+5.89%)

Close on Nov 18, 2026Market cap $1.44BP/E –Yield –

PROCEPT BioRobotics Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
64.2%
Operating margin
-33.9%
Net margin
-32.5%
Return on equity, FY2025
-24.9%

Financial strength

Current ratio
6.55
Debt to equity
0.15
Debt to assets
10.8%
Cash to current liabilities
355.0%

Valuation

P/E ratio
–
Price to sales
4.28
Price to book
4.24
Dividend yield
–

See a number that looks wrong?